Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site

被引:181
作者
Antonescu, CR
Viale, A
Sarran, L
Tschernyavsky, SJ
Gonen, M
Segal, NH
Maki, RG
Socci, ND
DeMatteo, RP
Besmer, P
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[5] Sloan Kettering Inst, Dept Mol Biol, New York, NY USA
[6] Sloan Kettering Inst, Computat Biol Ctr, New York, NY USA
[7] Sloan Ketterin Inst, Dev Biol Programs, New York, NY USA
关键词
D O I
10.1158/1078-0432.CCR-03-0715
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Gastrointestinal stromal tumors (GISTs) are specific KIT expressing and KIT-signaling driven mesenchymal tumors of the human digestive tract, many of which have KIT-activating mutations. Previous studies have found a relatively homogeneous gene expression profile in GIST, as compared with other histological types of sarcomas. Transcriptional heterogeneity within clinically or molecularly defined subsets of GISTs has not been previously reported. We tested the hypothesis that the gene expression profile in GISTs might be related to KIT genotype and possibly to other clinicopathological factors. Experimental Design: An HG-U133A Affymetrix chip (22,000 genes) platform was used to determine the variability of gene expression in 28 KIT-expressing GIST samples from 24 patients. A control group of six intra-abdominal leiomyosarcomas was also included for comparison. Statistical analyses (t tests) were performed to identify discriminatory gene lists among various GIST subgroups. The levels of expression of various GIST subsets were also linked to a modified version of the growth factor/KIT signaling pathway to analyze differences at various steps in signal transduction. Results: Genes involved in KIT signaling were differentially expressed among wild-type and mutant GISTs. High gene expression of potential drug targets, such as VEGF, MCSF, and BCL2 in the wild-type group, and Mesothelin in exon 9 GISTs were found. There was a striking difference in gene expression between stomach and small bowel GISTs. This finding was validated in four separate tumors, two gastric and two intestinal, from a patient with familial GIST with a germ-line KIT W557R substitution. Conclusions: GISTs have heterogeneous gene expression depending on KIT genotype and tumor location, which is seen at both the genomic level and the KIT signaling pathway in particular. These findings may explain their variable clinical behavior and response to therapy.
引用
收藏
页码:3282 / 3290
页数:9
相关论文
共 36 条
[1]   Expression profiling of synovial sarcoma by cDNA microarrays - Association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation [J].
Allander, SV ;
Illei, PB ;
Chen, YD ;
Antonescu, CR ;
Bittner, M ;
Ladanyi, M ;
Meltzer, PS .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) :1587-1595
[2]  
Antonescu CR, 2003, CLIN CANCER RES, V9, P3329
[3]  
BESMER P, 1997, COLONY STIMULATING F, P369
[4]   The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor [J].
Besmer, Peter .
CURRENT OPINION IN CELL BIOLOGY, 1991, 3 (06) :939-946
[5]   Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation [J].
Debiec-Rychter, M ;
Lasota, J ;
Sarlomo-Rikala, M ;
Kordek, R ;
Miettinen, M .
CANCER GENETICS AND CYTOGENETICS, 2001, 128 (01) :24-30
[6]   Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (ST1571) [J].
Demetri, GD .
EUROPEAN JOURNAL OF CANCER, 2002, 38 :S52-S59
[7]  
Ernst SI, 1998, LAB INVEST, V78, P1633
[8]  
Fan D, 2002, MOL CANCER THER, V1, P595
[9]   Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
HUMAN PATHOLOGY, 2002, 33 (05) :459-465
[10]  
Fletcher J.A., 2003, P AM SOC CLIN ONCOL, V22, P815